China Halts New Investments in Israel Over Security Concerns

China has reportedly suspended all new investments in Israel, citing heightened security risks linked to the ongoing conflict in the region. The revelation emerged through a lawsuit filed in Israel rather than an official announcement from Beijing, adding a new layer of complexity to already strained China–Israel relations.

The disclosure came from legal action initiated by members of Kibbutz Hanita against Ballet Vision, a Chinese-controlled investment fund that owns an 80 percent stake in Hanita Lenses, an intraocular lens manufacturing company located near Israel’s northern border.

According to court filings, the kibbutz is seeking approximately $11 million, alleging that Ballet Vision failed to honor an agreement to purchase the remaining shares in the company.

Attached to the lawsuit is a response letter from Ballet Vision stating that the Chinese government has designated Israel as a “high-risk” or “red category” area due to the regional security situation. The letter claims this classification, reportedly in effect since October 7, 2026, prevents Chinese entities from making new investments in Israel or the occupied Palestinian territories, effectively blocking the completion of the share purchase.

Liu Yuxiao, director of Ballet Vision and acting chief executive of Hanita Lenses, reiterated this position in a communication sent in December. He explained that the restrictions had forced the company to rely on shareholder loans instead of fresh capital injections.

Ballet Vision also pointed to deeper financial challenges, including operational losses exceeding $15 million over the past three years and a heavy debt burden, as factors complicating the transaction.

Despite the claims outlined in the lawsuit, Chinese authorities have not publicly confirmed the existence of a formal investment ban. Neither the Ministry of Commerce nor other official bodies in Beijing have issued statements verifying Israel’s alleged classification as a prohibited investment destination.

The case unfolds against the backdrop of evolving and increasingly delicate China–Israel relations. For years, ties between both countries were anchored in technology, infrastructure, and trade cooperation. Bilateral trade has remained strong, surpassing $16 billion in recent years, even as Washington has voiced concerns about Chinese involvement in sensitive Israeli technologies.

At the same time, Beijing has shown a willingness to impose targeted restrictions elsewhere on security grounds. China has previously banned the domestic use of certain U.S. and Israeli cybersecurity products, citing national security risks, signaling a more cautious approach to foreign technology partnerships.

In its filing at the Tel Aviv District Court, Kibbutz Hanita argues that Ballet Vision’s refusal to complete the deal violates contractual obligations and worsens the factory’s financial difficulties. The fund, however, maintains that a combination of internal financial strain and external constraints tied to China’s risk assessment makes compliance impossible.

As the lawsuit progresses, it may offer the clearest indication yet of how geopolitical tensions are reshaping China’s investment posture in Israel—whether through formal policy or quiet, risk-driven decisions by state-linked entities.